Skip to content
Screener

Reported April 29, 2026 · After market close

Revenue$1.0MBeat by $642.9K
EPS-$0.70Beat by $0.15
Revenue estimate$357.1K
EPS estimate-$0.85

Next report

Date not yet announced

FAQ

When did Catalyst Biosciences report Q1 2026 earnings?
Catalyst Biosciences (CBIO) reported Q1 2026 earnings on April 29, 2026 after market close.
What were Catalyst Biosciences's Q1 2026 revenue and EPS?
Catalyst Biosciences reported revenue of $1.0M and eps of $-0.70 for Q1 2026.
Did Catalyst Biosciences beat estimates in Q1 2026?
Revenue beat the consensus estimate of $357.1K by $642.9K. EPS beat the consensus estimate of $-0.85 by $0.15.
How did Catalyst Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 1650.0% from $-0.04.
Where can I find Catalyst Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-028386) and the 10-Q periodic report (0001628280-26-028362) directly on SEC EDGAR. The filing index links above go to sec.gov.